Meyka Pro is live. Get 50% off your first 3 months.Get Started →
Meyka Pro banner
IBIS HOLDINGS Co., Ltd.

IBIS HOLDINGS Co., Ltd. Fundamental Analysis (JPX: 9334.T)

9334.T●JPX
HealthcareMedical - Healthcare Information Services
¥1300.00
¥0.00(0.00%)
Japanese Market opens in 7h 2m

IBIS HOLDINGS Co., Ltd. Fundamental Analysis (JPX: 9334.T)

IBIS HOLDINGS Co., Ltd. (JPX: 9334.T) shows weak financial fundamentals with a PE ratio of 66.25, profit margin of N/A, and ROE of N/A. The company generates N/A in annual revenue with N/A year-over-year growth of N/A.

Key Strengths

No significant strengths identified.

Areas of Concern

No major concerns flagged.
We analyze 9334.T's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of 0.0/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

F
0.0/100

We analyze 9334.T's fundamental strength across five key dimensions:

Efficiency Score

Weak

9334.T struggles to generate sufficient returns from assets.

ROA > 10%
N/A

Valuation Score

Weak

9334.T trades at a premium to fair value.

PE < 25
66.25
PEG Ratio < 2
N/A

Growth Score

Moderate

9334.T shows steady but slowing expansion.

Revenue Growth > 5%
N/A
EPS Growth > 10%
N/A

Financial Health Score

Weak

9334.T carries high financial risk with limited liquidity.

Debt/Equity < 1
N/A
Current Ratio > 1
N/A

Profitability Score

Weak

9334.T struggles to sustain strong margins.

ROE > 15%
N/A
Net Margin ≥ 15%
N/A
Positive Free Cash Flow
N/A

Key Financial Metrics

Is 9334.T Expensive or Cheap?

P/E Ratio

9334.T trades at 66.25 times earnings. This suggests a premium valuation.

66.25

How Well Does 9334.T Make Money?

No data available.

Following the Money - Real Cash Generation

No data available.

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

N/A

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

N/A

vs 25 benchmark

P/B Ratio

Price to book value ratio

N/A

vs 25 benchmark

P/S Ratio

Price to sales ratio

N/A

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

N/A

vs 25 benchmark

Current Ratio

Current assets to current liabilities

N/A

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

N/A

vs 25 benchmark

ROA

Return on assets percentage

N/A

vs 25 benchmark

ROCE

Return on capital employed

N/A

vs 25 benchmark

How 9334.T Stacks Against Its Sector Peers

Metric9334.T ValueSector AveragePerformance
P/E RatioN/A32.02 N/A
ROEN/A569.00% N/A
Net MarginN/A29961.00% N/A
Debt/EquityN/A0.53 N/A
Current RatioN/A5.67 N/A
ROAN/A-96.00% (disorted) N/A

Historical Growth Performance

5-Year Growth Trajectory

This section reviews IBIS HOLDINGS Co., Ltd.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

N/A

Industry Style: Defensive, Growth, Innovation

EPS CAGR

N/A

Industry Style: Defensive, Growth, Innovation

FCF CAGR

N/A

Industry Style: Defensive, Growth, Innovation

Fundamental Analysis FAQ